Article Text

Download PDFPDF

Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis
  1. Santiago Bernal-Macías1,2,
  2. Benjamín Reyes-Beltrán1,2,
  3. Nicolás Molano-González1,
  4. Daniel Augusto Vega2,
  5. Claudia Bichernall2,
  6. Luis Aurelio Díaz3,
  7. Adriana Rojas-Villarraga1,2 and
  8. Juan-Manuel Anaya1,2
  1. 1Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia
  2. 2Intensive Care Unit, Mederi, Hospital Universitario Mayor, Bogotá, Colombia
  3. 3Intensive Care Unit, Macon Lung Center, Macon, Georgia, USA
  1. Correspondence to Professor Juan-Manuel Anaya; anayajm{at}gmail.com

Abstract

Objectives The interest on autoimmune diseases (ADs) and their outcome at the intensive care unit (ICU) has increased due to the clinical challenge for diagnosis and management as well as for prognosis. The current work presents a-year experience on these topics in a tertiary hospital.

Methods The mixed-cluster methodology based on multivariate descriptive methods such as principal component analysis and multiple correspondence analyses was performed to summarize sets of related variables with strong associations and common clinical context.

Results Fifty adult patients with ADs with a mean age of 46.7±17.55 years were assessed. The two most common diagnoses were systemic lupus erythematosus and systemic sclerosis, registered in 45% and 20% of patients, respectively. The main causes of admission to ICU were infection and AD flare up, observed in 36% and 24%, respectively. Mortality during ICU stay was 24%. The length of hospital stay before ICU admission, shock, vasopressors, mechanical ventilation, abdominal sepsis, Glasgow score and plasmapheresis were all factors associated with mortality. Two new clinical clusters variables (NCVs) were defined: Time ICU and ICU Support Profile, which were associated with survivor and no survivor variables.

Conclusions Identification of single factors and groups of factors from NCVs will allow implementation of early and aggressive therapies in patients with ADs at the ICU in order to avoid fatal outcomes

  • Autoimmune Diseases
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Arthritis
  • Outcomes research

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.